<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is a <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> in which stratified squamous type mucosa of the <z:mpath ids='MPATH_458'>normal</z:mpath> oesophagus is replaced by specialised intestinal type columnar mucosa </plain></SENT>
<SENT sid="1" pm="."><plain>Oesophageal resection was previously considered to be the treatment of choice for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or superficial <z:mp ids='MP_0002038'>carcinoma</z:mp> arising in this columnar-lined mucosa </plain></SENT>
<SENT sid="2" pm="."><plain>We treated four patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and one patient with superficial oesophageal <z:mp ids='MP_0002038'>carcinoma</z:mp> with photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) using an <z:chebi fb="17" ids="49474,49475">argon</z:chebi>-pumped dye laser light (652 nm) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> was also delivered using a <z:chebi fb="3" ids="49957">xenon</z:chebi> arc lamp (Paterson lamp, light 652 nm +/- 15 nm) in two patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="9437">mTHPC</z:chebi> (m-tetrahydroxyphenyl <z:chebi fb="0" ids="36303">chlorin</z:chebi>) 0.15 mg/kg was used as a photosensitiser in <z:hpo ids='HP_0000001'>all</z:hpo> the patients </plain></SENT>
<SENT sid="5" pm="."><plain>We have been able to demonstrate the elimination of columnar-lined oesophageal mucosa, reduction in the length of the Barrett's segment or downgrading of the <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> of the patients </plain></SENT>
<SENT sid="6" pm="."><plain>There is no evidence of recurrence in the patient who had oesophageal <z:mp ids='MP_0002038'>carcinoma</z:mp>, at 27 months follow-up </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that <z:chebi fb="0" ids="9437">mTHPC</z:chebi> is useful as a photosensitiser for <z:chebi fb="7" ids="53228">PDT</z:chebi> in the management of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or superficial <z:mp ids='MP_0002038'>carcinoma</z:mp> and the Paterson lamp is a potential alternative light source for <z:chebi fb="7" ids="53228">PDT</z:chebi> </plain></SENT>
</text></document>